ONOJO, Japan, August 08, 2022--(BUSINESS WIRE)--In August 2022, the Japanese electric bed for elderly brand PLATZ (TOKYO:7813) announced that Ai Fukuhara became the brand's spokesperson. PLATZ is a Japanese brand with a 30-year history of developing and producing electric beds for the elderly.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220802005610/en/
The PLATZ bed for the elderly can be powered up and has a guardrail, which is suitable for the elderly who have difficulty getting up and are at risk of falling. (Graphic: Business Wire)
According to the Technical Guidelines for Falls Intervention in the Elderly issued by the Chinese Ministry of Health, falls are the leading cause of injury-related death among the elderly over 65 years old in China. In addition to the death of the elderly, falls also lead to a large number of disabilities and affect the physical and mental health of the elderly. It is estimated that an average of 40 million elderly people in China fall once a year.
For example, getting out of bed in the morning or at night is a high-incidence scene of falls in the elderly. For different scenarios, in addition to strengthening the stability of the bed and guardrails, the PLATZ Bed for the Elderly also provides users with free home-based fall prevention consulting services. These include fall risk assessment for the elderly, risk assessment of the home environment, and provision of corresponding improvement programs.
Ai Fukuhara's mother injured her lower back two years ago and needed a wheelchair for daily activities. Therefore, Ai Fukuhara has always been very concerned about the safety and health of the elderly. "My mother was hurt, So My heart aches for her." For the safety and health of parents all over the world, Ai Fukuhara said that she will fully support PLATZ to work with caring brothers and sisters to solve the problem of preventing falls in the elderly.
Official Weibo https://weibo.com/u/7765833547 Official website http://www.platz-cn.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220802005610/en/
Hiroshi Yoshino Email: hiroshi.yoshino@platz-ltd.co.jp +81-80-6407-3698
According to the World Health Organization, health officials are witnessing early signs that the new monkeypox case growth may be waning in Europe and the U.S. Public-health experts said they remain cautious about whether the outbreak has peaked as efforts continue to stretch limited vaccine supplies and protect vulnerable individuals. “If anything, we need to continue to strongly communicate and educate the public about this pathogen,” said Rodney Rohde, a public-health expert at Texas State Un
The Medicines and Healthcare products Regulatory Agency in the U.K. has granted expanded conditional approval for Novavax Inc's (NASDAQ: NVAX) COVID-19 vaccine, Nuvaxovid (NVX-CoV2373), in adolescents aged 12 through 17. The approval follows the FDA nod earlier this week. "As we start to prepare for a potential fall surge, we are pleased to offer the first protein-based COVID-19 vaccine to adolescents aged 12 through 17 in the U.K.," said Stanley C. Erck, President, and CEO, of Novavax. The expa
Merck's rumored takeover of cancer-focused biotech Seagen has stalled on price, according to a report Friday that sent SGEN stock tumbling.
Iovance (IOVA) starts a rolling BLA submission with the FDA seeking approval for its lead pipeline candidate in advanced melanoma patients. The filing is expected to be completed by fourth-quarter 2022.
Novartis (NVS) plans to spin off its generics division, Sandoz. The FDA approves J&J (JNJ) and AbbVie's (ABBV) Imbruvica for pediatric indication cGVHD.
(Bloomberg) -- Merck & Co.’s talks to buy cancer-drug maker Seagen Inc. have stalled for now, threatening what would be the pharmaceutical giant’s biggest deal in more than a decade, according to people familiar with the matter.Most Read from BloombergNearly 60,000 Sneakers in $85 Million Ponzi Scheme to Go on SaleGOP Fury Over ESG Triggers Backlash With US Pensions at RiskFed’s Jackson Hole Conference Is Underway: Here’s What to ExpectWorld’s Most Popular Password Manager Says It Was HackedA 12
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced first patient dosing in its Phase 2b dose-optimization trial of MM-120, a pharmaceutically optimized form of lysergic acid diethylamide (LSD), for the treatment of Generalized Anxiety Disorder (GAD).
Teladoc Health (NYSE: TDOC) the global leader in whole-person virtual care, together with Cloud DX (TSXV: CDX) (OTC: CDXFF), a leading remote patient monitoring ("RPM") platform, are pleased to announce that they have entered into a strategic partnership to better serve the remote monitoring needs of patients across Canada.
Kodiak Sciences (KOD) has progressed well with the development of its lead pipeline candidate, tarcocimab, for treating various retinal vascular diseases.
The Miami-Dade Police Department is launching an investigation after a viral video shows an officer refusing to let a pregnant woman go to the emergency room
Alnylam's (ALNY) portfolio of approved drugs is witnessing a strong uptake while its pipeline is progressing well. The recent FDA approval of Amvuttra for a rare disease is a positive.
SIGA has received $60 million in orders for Tpoxx, which was developed to treat smallpox in the event of an attack.
Bristol Myers (BMY) has put up an impressive performance so far in 2022, and the momentum should continue on label expansion of existing drugs.
When does breastmilk stop providing nutrients to a child? Experts explain.
Photo Illustration by Luis G. Rendon/The Daily Beast/GettyFederal COVID funding is beginning to run out in the U.S. As the once-extensive government investment in vaccines, therapies and testing vanishes, epidemiologists are bracing for a major shakeup in—some would say “collapse of”—critical efforts to contain the SARS-CoV-2 virus.Vaccine initiatives could suffer the biggest blow. With the impending end of government funding, Americans would have to start paying for their own COVID shots—a disi
With school back in session, there are no reports of COVID-19 breakouts in the three counties.
North Korea on Friday said the latest fever cases detected in its border region with China were tested to be influenza, not coronavirus infections as initially feared. The report by North Korea’s official Korean Central News Agency came a day after the North said it locked down unspecified areas in Ryanggang province after four people had fevers that were suspected to be COVID-19. KCNA said diagnostic tests of samples, the nature of the symptoms, and information gained from contract tracing led health workers to conclude that the fevers were caused by influenza.
Getting rid of water weight is one of the most frustrating things for any dieter, but there are safe and proven ways to reduce water retention. Here's what to know.
The United States plans to roll out an updated COVID-19 booster vaccine to include Omicron subvariants of the coronavirus. ARE WE GETTING NEW VACCINES? Pfizer Inc with partner BioNTech SE and Moderna Inc completed applications this week to the U.S. Food and Drug Administration for COVID-19 vaccine boosters retooled to target versions of the Omicron variant of the virus.
Statins provide limited use unless patients stay on them for life, research suggests.